Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  calcium citrate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-10 of 10 for your search:
Start Over
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0518, CDR0000476469, NCI-2009-00884, 0518, NCT00329797
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0517, CDR0000491233, NCI-2009-00727, NCT00365105
A Study of Actonel for the Prevention of Bone Loss
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: ID03-0124, NCI-2010-01997, NCT00452439
Women's Health Initiative (WHI)
Phase: Phase III
Type: Health services research, Natural history/Epidemiology, Prevention
Status: Completed
Age: 50 to 79
Sponsor: NCI, NHLBI
Protocol IDs: 114, NCT00000611
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27
Phase: Phase III
Type: Natural history/Epidemiology, Supportive care
Status: Completed
Age: 45 and over
Sponsor: NCI, Other
Protocol IDs: MA27B, CAN-NCIC-MA27B, SWOG-NCIC-MA27B, NCCTG-NCIC-MA27B, CAN-NCIC-BONE, CDR0000483099, NCIC-MA.27B, NCT00354302
Oral Glutamine in the Prevention of Oxaliplatin-induced Neurotoxicity
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OXALI_L_03768, U1111-1116-9494, NCT01087658
Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005NT018, UMN-0506M70866, UMN-MT2005-06, NOVARTIS-CZOL446EUS29, UMN-2005NT018, NCT00321932
Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer
Phase: Phase II
Type: Natural history/Epidemiology, Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 6346, NCI-2010-00621, UWCC-6346, NOVARTIS-UWCC-6346, UWCC-06-2386-H/A, FHCRC-6346, NCT00416715
Nutrition and Body Composition in Acute Lymphoblastic Leukemia
Phase: Phase II
Type: Supportive care
Status: Closed
Age: 10 to 21
Sponsor: Other
Protocol IDs: CCI-10-00273, LLS 6249-11, NCT01317940
Phase I Study of Two Calcium Compounds in Patients with Previously Resected Dukes' Stages A/B/C Adenocarcinoma of the Colon (Summary Last Modified 03/93)
Phase: Phase I
Type: Prevention
Status: Closed
Age: 30 to 80
Sponsor:
Protocol IDs: MDA-DM-90046, NCI-P93-0036
Start Over